• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Gevo Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

    2/3/25 9:05:13 AM ET
    $GEVO
    Major Chemicals
    Industrials
    Get the next $GEVO alert in real time by email
    false 0001392380 0001392380 2025-01-31 2025-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): January 31, 2025

     

     

    Gevo, Inc.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware 001-35073 87-0747704
    (State or other jurisdiction (Commission File Number) (IRS Employer
    of incorporation)   Identification No.)

     

    345 Inverness Drive South, Building C, Suite 310
    Englewood
    , CO 80112

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (303) 858-8358

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading symbol   Name of exchange on which registered
    Common Stock, par value $0.01 per share   GEVO   Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 1.01. Entry into a Material Definitive Agreement.

     

    On January 31, 2025 (the “Closing Date”), Gevo, Inc., a Delaware corporation (the “Company”), closed its previously announced transaction pursuant to that certain Asset Purchase Agreement (the “Purchase Agreement”) by and among the Company and its wholly owned subsidiaries Richardton CCS, LLC, a Delaware limited liability company (“R-CCS”), and Net-Zero Richardton, LLC, a Delaware limited liability company (“NZ-R”, and together with R-CCS, the “Buyers”), and Red Trail Energy, LLC, a North Dakota limited liability company (“Seller”). Pursuant to the Purchase Agreement, and subject to the terms and conditions thereof, the Buyers acquired substantially all of the assets, and assumed certain liabilities, of Seller on the terms set forth therein (the “Transaction”).

     

    Credit Agreement

     

    On the Closing Date, Net-Zero North HoldCo, LLC, a Delaware limited liability company (the “Borrower”), R-CCS, NZ-R (R-CCS, NZ-R and Borrower collectively , the “Project Companies”), Gevo North Dakota Operations, LLC, a Delaware limited liability company (“Operations Company”), and Gevo Intermediate HoldCo, LLC, a Delaware limited liability company (“Holdings”, and together with the Project Companies and the Operations Company, the “Guarantors”), each a direct or indirect subsidiary of the Company, entered into a Credit Agreement (the “Credit Agreement”) with OIC Investment Agent, LLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”) and as collateral agent for the Secured Parties (in such capacity, the “Collateral Agent”), and the lenders from time to time thereto (“Lenders”).

     

    The Credit Agreement provides for a $105 million senior secured term loan that was funded on the Closing Date (the “Term Loan”) with a maturity of January 31, 2030. The proceeds of the Term Loan were used to partially fund the previously announced Transaction and the payment of fees under the Credit Agreement. The Credit Agreement also provides for additional uncommitted term loans in an aggregate amount to be mutually agreed upon by the Borrower, the Guarantors and the Lenders for use for certain future growth opportunities after the Closing Date. Interest on the Term Loan will accrue at a rate of (i) 10.00% per annum if the net leverage ratio as of the last day of the quarter for the measurement period (the “Measurement Period”) consisting of the prior four consecutive fiscal quarters of the Borrower (“Leverage Ratio”) is less than 1.5x, (ii) 10.75% per annum if the Leverage Ratio is equal to or greater than 1.5x, but less than 3.0x, and (iii) 11.50% per annum if the Leverage Ratio is equal to or greater than 3.0x and shall initially be set at 11.50% per annum until the next quarterly adjustment date. The Leverage Ratio is defined as the ratio of the combined indebtedness of the Borrower and the Guarantors (other than any indebtedness pursuant to any permitted working capital facility) less any cash equivalent investments in any collateral accounts to the consolidated EBITDA of the Borrower and Guarantors for the relevant Measurement Period. Interest will be due and payable in cash at the end of each quarter.

     

    In connection with the Term Loan, and subject to the other terms under the Credit Agreement, Lenders made an equity investment in Holdings equal to $5 million on the Closing Date. The organizational documents of Holdings also provide Lenders with the right to appoint two non-voting observers to the board of managers of Holdings. Other than the transactions described herein, the Lenders and the Collateral Agent do not have any material relationship with the Company or its affiliates.

     

    The Term Loan is secured by a first-lien security interest subject only to reasonable and customary permitted liens and encumbrances, in all the Borrower’s and each Guarantor’s tangible and intangible assets, properties controlled by Borrower and Guarantors, and contracts, including deposit accounts and collateral assignment of material contracts and certain real estate assets to be determined, and includes a pledge of all equity interests in the Borrower and its subsidiaries. The Credit Agreement also contains customary affirmative and negative covenants, events of default, mandatory prepayments (including an excess cash flow sweep), conditions precedent, representations, and warranties.

     

    The foregoing descriptions of the Credit Agreement and the Term Loan do not purport to be complete and are subject to, and qualified in their entirety by, the full texts of the Credit Agreement and Form of Term Loan Note, copies of which are filed herewith as Exhibits 10.1 and 10.2, and are incorporated herein by reference.

     

     

     

     

    Item 2.01. Completion of Acquisition or Disposition of Assets.

     

    The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

     

    The aggregate purchase price was $210 million, subject to customary adjustments, including a working capital adjustment (the “Purchase Price”). The Purchase Price was funded by a mixture of Company cash on hand and $105 million of debt financing from the Term Loan.

     

    As previously disclosed, the Company and Seller entered into an escrow agreement pursuant to which the Company had deposited $10 million in earnest money, which was applied against the Purchase Price. In addition, pursuant to such escrow agreement, the Company deposited on the Closing Date (i) $1.26 million of the Purchase Price for the purposes of securing the post-closing indemnification obligations of Seller, and (ii) $5 million of the Purchase Price for purposes of securing any Purchase Price adjustments. Buyers obtained a representation and warranty insurance policy to provide coverage for certain breaches of representations and warranties of the Sellers, which coverage is subject to certain exclusions, deductibles and other terms and conditions as set forth in the policy.

     

    The material terms of the Purchase Agreement were previously reported in Item 1.01 of the Current Report on Form 8-K filed on September 12, 2024 (the “September Form 8-K”) with the U.S. Securities and Exchange Commission (the “SEC”). The foregoing description of the Purchase Agreement and the Transaction contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, a copy of which was filed with the SEC as Exhibit 2.1 to the September Form 8-K, and is incorporated herein by reference.

     

    Item 2.03. Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

     

    The information set forth in Items 1.01 and 2.01 of this Current Report on Form 8-K are incorporated herein by reference.

     

    Item 7.01. Regulation FD Disclosure.

     

    On February 3, 2025, the Company announced the closing of the Transaction. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein.

     

    The information in Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for purposes of Section 18 of Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (a) Financial statements of businesses or funds acquired.

     

    The Company intends to file the financial statements required by Item 9.01(a) by amendment to this Current Report on Form 8-K not later than 71 calendar days after the date that this Current Report on Form 8-K is required to be filed with respect to the closing of the Transaction.

     

    (b) Pro forma financial information.

     

    The Company intends to file the pro forma financial information relating to the Transaction required by Item 9.01(b) by amendment to this Current Report on Form 8-K not later than 71 calendar days after the date that this Current Report on Form 8-K is required to be filed with respect to the closing of the Transaction.

     

     

     

     

    (d) Exhibits.

     

    Exhibit 
    No.
      Description
    2.1*   Asset Purchase Agreement, dated as of September 10, 2024, by and among the Company, Buyers, and Seller (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 12, 2024).
    10.1*   Credit Agreement, dated as of January 31, 2025, by and between the Net-Zero North HoldCo, LLC, OIC Investment Agent, LLC, as administrative agent for the Lenders, and the other parties thereto.
    10.2   Form of Term Loan Note
    99.1   Press Release, dated February 3, 2025
    104   Cover Page Interactive Data File (embedded as Inline XBRL document)

     

      * Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon its request.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      GEVO, INC.
         
    Dated: February 3, 2025 By: /s/ E. Cabell Massey
        E. Cabell Massey
        Vice President, Legal and Corporate Secretary

     

     

     

    Get the next $GEVO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEVO

    DatePrice TargetRatingAnalyst
    8/21/2023$2.00Market Perform
    Northland Capital
    12/14/2022$2.25Neutral
    UBS
    10/19/2022$2.29Hold
    Jefferies
    2/9/2022$5.00Buy
    Citigroup
    8/24/2021$10.00Buy
    Stifel
    More analyst ratings

    $GEVO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Gevo Promotes Lindsay Fitzgerald to Chief Advocacy and Communications Officer

      ENGLEWOOD, Colo., June 03, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today the promotion of Lindsay Fitzgerald to Chief Advocacy and Communications Officer, effective immediately. In this expanded leadership role, Ms. Fitzgerald will focus on advancing Gevo's mission to strengthen American energy and food security by unlocking the full value of U.S. agriculture and rural communities. She continues to drive policy advocacy and public communications that support cost-effective, American-made hydrocarbon fuels and chemicals, while building free-market solutions for carbon abatement and economic growth. Her efforts help bolster U.S. agriculture as the most sustainable in the

      6/3/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo to Sell Luverne, Minnesota Ethanol Facility to A.E. Innovation; Will Retain Isobutanol Assets for Future Innovation

      ENGLEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that it has entered into a definitive agreement to sell Agri-Energy, LLC ("Agri"), a wholly owned subsidiary of Gevo, to A.E. Innovation, LLC ("A.E.") for $7 million. The transaction includes Agri's 18-million-gallon-per-year ethanol-production facility located in Luverne, Minnesota. Gevo will retain ownership of certain isobutanol-production-related assets and a portion of the vacant land at the site for future use. With these retained assets, Gevo could potentially produce up to 1 million gallons per year of isobutanol, which can be sold as a specialty chemical, or converted into isooctane

      5/28/25 9:00:00 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Appoints Industry Veteran James Barber, Ph.D. to Board of Directors

      ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corporation (NYSE:GHM), where he chairs the Compensation Committee and is a member of the Audit and Nomination and Governance Committees. Dr. Barber holds a Ph.D. in Organic Chemistry from the

      5/27/25 4:10:00 PM ET
      $GEVO
      $GHM
      Major Chemicals
      Industrials
      Industrial Machinery/Components

    $GEVO
    Leadership Updates

    Live Leadership Updates

    See more
    • Gevo Appoints Industry Veteran James Barber, Ph.D. to Board of Directors

      ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corporation (NYSE:GHM), where he chairs the Compensation Committee and is a member of the Audit and Nomination and Governance Committees. Dr. Barber holds a Ph.D. in Organic Chemistry from the

      5/27/25 4:10:00 PM ET
      $GEVO
      $GHM
      Major Chemicals
      Industrials
      Industrial Machinery/Components
    • Gevo Promotes Leke Agiri to Chief Financial Officer

      ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), is pleased to announce the appointment of Oluwagbemileke (Leke) Agiri as Chief Financial Officer, effective as of May 21, 2025. Mr. Agiri succeeds L. Lynn Smull, who will continue with the Company in a new role as Executive Vice President and Senior Advisor to the Chief Executive Officer, focusing on strategic initiatives and to aide and support a seamless transition. Mr. Agiri brings extensive experience and leadership in corporate finance, capital markets, and strategic growth, both organic and inorganic. Since joining Gevo in August 2022, he has served in key leadership roles, most recently as Executive Vice P

      5/27/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Announces Appointment of Katie Ellet to Board of Directors

      ENGLEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that Katie Ellet has been appointed to its board of directors as of January 2, 2024. Ms. Ellet serves as president, Hydrogen Energy and Mobility for North America at Air Liquide, a world leader in gases, technologies and services for Industry and Health, and a global innovator in low carbon hydrogen production. She has held a wide variety of leadership roles in the chemical and energy fields for the last 27 years. "We are honored to have Katie join our Board of Directors," said Dr. Patrick Gruber, CEO of Gevo. "She has a demonstrated record of technology expertise, market knowledge, and inn

      1/3/24 4:05:00 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Financials

    Live finance-specific insights

    See more
    • Gevo Reports First Quarter 2025 Financial Results

      Quarterly Revenue Increased $25 Million Compared to First Quarter of 2024 Due to Strategic Growth Initiatives  Further Revenue and Adjusted EBITDA1 Growth is Expected in 2025  Gevo to Host Conference Call Today at 4:30 p.m. ET ENGLEWOOD, Colo., May 13, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost-effective, renewable hydrocarbon fuels and chemicals that also can deliver significant carbon emission abatement, today announced financial results for the first quarter ended March 31, 2025. Recent Corporate Highlights: Continuing on a Path to Positive Adjusted EBITDA1  Revenue and Adjusted EBITDA growth: Total op

      5/13/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo to Report First Quarter 2025 Financial Results on May 13, 2025

      ENGLEWOOD, Colo., April 29, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host a conference call on May 13, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the first quarter ended March 31, 2025. To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BI14d4db26011d45b9871ce05b8b3c5a63   After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/xd9v2i3x   A webcast replay will be available two hou

      4/29/25 9:30:00 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Reports Fourth Quarter 2024 Financial Results and Reaffirms Business Update

      ENGLEWOOD, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, today announced financial results for the fourth quarter and full year ended December 31, 2024, and reaffirmed the Business Update that was released on March 7, 2025 (the "Business Update"), which is available on our website at https://investors.gevo.com/news-releases/news-release-details/gevo-provides-business-update-1. 2024 Fourth Quarter Financial Highlights Ended the fourth quarter with cash, cash equ

      3/27/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    SEC Filings

    See more
    • SEC Form S-8 filed by Gevo Inc.

      S-8 - Gevo, Inc. (0001392380) (Filer)

      6/5/25 7:38:48 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • SEC Form 144 filed by Gevo Inc.

      144 - Gevo, Inc. (0001392380) (Subject)

      6/3/25 4:05:51 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Gevo, Inc. (0001392380) (Filer)

      5/27/25 4:01:41 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Northland Capital initiated coverage on Gevo with a new price target

      Northland Capital initiated coverage of Gevo with a rating of Market Perform and set a new price target of $2.00

      8/21/23 9:21:52 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • UBS initiated coverage on Gevo with a new price target

      UBS initiated coverage of Gevo with a rating of Neutral and set a new price target of $2.25

      12/14/22 7:48:29 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Jefferies initiated coverage on Gevo with a new price target

      Jefferies initiated coverage of Gevo with a rating of Hold and set a new price target of $2.30

      10/19/22 8:39:11 AM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Gevo Inc.

      SC 13G/A - Gevo, Inc. (0001392380) (Subject)

      11/12/24 4:02:11 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Gevo Inc.

      SC 13G/A - Gevo, Inc. (0001392380) (Subject)

      11/4/24 11:58:10 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Gevo Inc.

      SC 13G/A - Gevo, Inc. (0001392380) (Subject)

      7/8/24 4:32:39 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO Agiri Oluwagbemileke Yusuf sold $12,572 worth of shares (10,810 units at $1.16), decreasing direct ownership by 7% to 152,140 units (SEC Form 4)

      4 - Gevo, Inc. (0001392380) (Issuer)

      6/4/25 5:35:08 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Chief Advocacy & Comms Officer Fitzgerald Lindsay Clinton sold $10,452 worth of shares (8,987 units at $1.16), decreasing direct ownership by 5% to 161,469 units (SEC Form 4)

      4 - Gevo, Inc. (0001392380) (Issuer)

      6/4/25 5:35:05 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • New insider Agiri Oluwagbemileke Yusuf claimed ownership of 181,950 shares (SEC Form 3)

      3 - Gevo, Inc. (0001392380) (Issuer)

      6/3/25 5:34:48 PM ET
      $GEVO
      Major Chemicals
      Industrials